hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_02928.1
Confidence: Extremely High
Proteins| Genename | Protein Name | Uniprot Annotation Score | Links |
|---|---|---|---|
| NDUFB3 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12) (CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit) | 5 | UniProt NCBI |
| MT-ND5 | NADH-ubiquinone oxidoreductase chain 5 (EC 7.1.1.2) (NADH dehydrogenase subunit 5) | 5 | UniProt NCBI |
| NDUFB10 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (Complex I-PDSW) (CI-PDSW) (NADH-ubiquinone oxidoreductase PDSW subunit) | 5 | UniProt NCBI |
| MT-ND2 | NADH-ubiquinone oxidoreductase chain 2 (EC 7.1.1.2) (NADH dehydrogenase subunit 2) | 5 | UniProt NCBI |
| NDUFV3 | NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial (Complex I-9kD) (CI-9kD) (NADH-ubiquinone oxidoreductase 9 kDa subunit) (Renal carcinoma antigen NY-REN-4) | 5 | UniProt NCBI |
| DNAJC30 | DnaJ homolog subfamily C member 30, mitochondrial (Williams-Beuren syndrome chromosomal region 18 protein) | 5 | UniProt NCBI |
| NDUFB2 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial (Complex I-AGGG) (CI-AGGG) (NADH-ubiquinone oxidoreductase AGGG subunit) | 4 | UniProt NCBI |
| NDUFB11 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (Complex I-ESSS) (CI-ESSS) (NADH-ubiquinone oxidoreductase ESSS subunit) (Neuronal protein 17.3) (Np17.3) (p17.3) | 5 | UniProt NCBI |
| NDUFA7 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 (Complex I-B14.5a) (CI-B14.5a) (NADH-ubiquinone oxidoreductase subunit B14.5a) | 5 | UniProt NCBI |
| MT-ND1 | NADH-ubiquinone oxidoreductase chain 1 (EC 7.1.1.2) (NADH dehydrogenase subunit 1) | 5 | UniProt NCBI |
| NDUFS8 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (EC 7.1.1.2) (Complex I-23kD) (CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit) (TYKY subunit) | 5 | UniProt NCBI |
| NDUFB9 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (LYR motif-containing protein 3) (NADH-ubiquinone oxidoreductase B22 subunit) | 5 | UniProt NCBI |
| NDUFA3 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 (Complex I-B9) (CI-B9) (NADH-ubiquinone oxidoreductase B9 subunit) | 5 | UniProt NCBI |
| NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (Complex I-MWFE) (CI-MWFE) (NADH-ubiquinone oxidoreductase MWFE subunit) | 5 | UniProt NCBI |
Enrichments
| Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
|---|---|---|---|---|
| CORUM:178 | 1.2031606845e-31 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Respiratory chain complex I (holoenzyme), mitochondrial |
| GO:0042776 | 8.08394858327e-30 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | proton motive force-driven mitochondrial ATP synthesis |
| GO:0015986 | 4.17857099097e-29 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | proton motive force-driven ATP synthesis |
| REAC:R-HSA-6799198 | 4.33051183555e-29 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Complex I biogenesis |
| GO:0006754 | 4.7540109335e-28 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | ATP biosynthetic process |
| GO:0009206 | 6.86231143445e-28 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | purine ribonucleoside triphosphate biosynthetic process |
| GO:0009145 | 6.86231143445e-28 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | purine nucleoside triphosphate biosynthetic process |
| GO:0045271 | 8.27191779239e-28 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | respiratory chain complex I |
| GO:0005747 | 8.27191779239e-28 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | mitochondrial respiratory chain complex I |
| GO:0030964 | 8.27191779239e-28 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | NADH dehydrogenase complex |
| GO:0009201 | 1.65033854796e-27 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | ribonucleoside triphosphate biosynthetic process |
| GO:0009142 | 2.72424305764e-27 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | nucleoside triphosphate biosynthetic process |
| WP:WP4324 | 2.3447680153e-26 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFA3 NDUFA7 NDUFB10 | Mitochondrial complex I assembly model OXPHOS system |
| REAC:R-HSA-611105 | 1.09127079091e-25 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Respiratory electron transport |
| GO:0006119 | 1.12813575231e-25 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | oxidative phosphorylation |
| GO:0008137 | 1.28337276362e-25 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | NADH dehydrogenase (ubiquinone) activity |
| GO:0050136 | 1.81419377336e-25 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | NADH dehydrogenase (quinone) activity |
| GO:0003954 | 2.53954959859e-25 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | NADH dehydrogenase activity |
| KEGG:04723 | 2.7243096079e-25 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Retrograde endocannabinoid signaling |
| KEGG:00190 | 3.83058809512e-25 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Oxidative phosphorylation |
| GO:0003955 | 4.84234950022e-25 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | NAD(P)H dehydrogenase (quinone) activity |
| GO:0006120 | 6.60236738574e-25 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | mitochondrial electron transport, NADH to ubiquinone |
| GO:0098803 | 8.29791171733e-25 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | respiratory chain complex |
| REAC:R-HSA-163200 | 1.72862034795e-24 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| GO:0005746 | 2.3219124739e-24 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | mitochondrial respirasome |
| GO:0070469 | 2.3219124739e-24 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | respirasome |
| GO:0009060 | 3.51127664968e-24 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | aerobic respiration |
| GO:0009152 | 7.54779421474e-24 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | purine ribonucleotide biosynthetic process |
| GO:0016655 | 1.28008104577e-23 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor |
| GO:0046034 | 1.55931428342e-23 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | ATP metabolic process |
| GO:0009260 | 1.70293533584e-23 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | ribonucleotide biosynthetic process |
| GO:0015453 | 2.04390095393e-23 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | oxidoreduction-driven active transmembrane transporter activity |
| GO:0045333 | 2.21088811378e-23 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | cellular respiration |
| GO:0046390 | 2.8566623161e-23 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | ribose phosphate biosynthetic process |
| WP:WP111 | 4.31779841392e-23 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Electron transport chain OXPHOS system in mitochondria |
| GO:0009205 | 4.33443643255e-23 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | purine ribonucleoside triphosphate metabolic process |
| GO:0009144 | 5.10361469379e-23 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | purine nucleoside triphosphate metabolic process |
| GO:0009199 | 7.03608198581e-23 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | ribonucleoside triphosphate metabolic process |
| KEGG:05415 | 8.64903867729e-23 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Diabetic cardiomyopathy |
| GO:0006164 | 9.63064582602e-23 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | purine nucleotide biosynthetic process |
| GO:1990204 | 1.06596774839e-22 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | oxidoreductase complex |
| GO:0009141 | 1.21318966307e-22 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | nucleoside triphosphate metabolic process |
| GO:0072522 | 1.41211487729e-22 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | purine-containing compound biosynthetic process |
| REAC:R-HSA-1428517 | 1.61150876631e-22 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | The citric acid (TCA) cycle and respiratory electron transport |
| KEGG:05208 | 3.50203631548e-22 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Chemical carcinogenesis - reactive oxygen species |
| KEGG:04714 | 4.26607656601e-22 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Thermogenesis |
| GO:0009165 | 4.49909385104e-22 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | nucleotide biosynthetic process |
| GO:0016651 | 5.01915425462e-22 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | oxidoreductase activity, acting on NAD(P)H |
| GO:1901293 | 5.92497947967e-22 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | nucleoside phosphate biosynthetic process |
| GO:0019646 | 7.09372953399e-22 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | aerobic electron transport chain |
| GO:0015980 | 1.22983775243e-21 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | energy derivation by oxidation of organic compounds |
| GO:0042773 | 1.89302754377e-21 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | ATP synthesis coupled electron transport |
| GO:0042775 | 1.89302754377e-21 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | mitochondrial ATP synthesis coupled electron transport |
| KEGG:05012 | 3.13056470974e-21 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Parkinson disease |
| GO:0098800 | 4.35686983345e-21 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | inner mitochondrial membrane protein complex |
| KEGG:05020 | 4.60572305355e-21 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Prion disease |
| GO:0022904 | 7.20076004539e-21 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | respiratory electron transport chain |
| GO:0009055 | 1.62572555789e-20 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | electron transfer activity |
| KEGG:05016 | 1.76084529084e-20 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Huntington disease |
| GO:0022900 | 2.1075621482e-20 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | electron transport chain |
| GO:0032981 | 3.81044380614e-20 | 0.785714285714 | NDUFB3 MT-ND5 NDUFA3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | mitochondrial respiratory chain complex I assembly |
| GO:0010257 | 3.81044380614e-20 | 0.785714285714 | NDUFB3 MT-ND5 NDUFA3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | NADH dehydrogenase complex assembly |
| WP:WP623 | 5.92799744668e-20 | 0.714285714286 | NDUFV3 MT-ND5 NDUFA3 NDUFB2 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA7 NDUFB10 | Oxidative phosphorylation |
| GO:0009150 | 1.67417417244e-19 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | purine ribonucleotide metabolic process |
| KEGG:05014 | 1.878272936e-19 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Amyotrophic lateral sclerosis |
| GO:0009259 | 2.62067745541e-19 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | ribonucleotide metabolic process |
| KEGG:05010 | 3.55218627661e-19 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Alzheimer disease |
| GO:0006091 | 4.40567318041e-19 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | generation of precursor metabolites and energy |
| GO:0019693 | 4.40567318041e-19 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | ribose phosphate metabolic process |
| GO:0015399 | 5.38960764101e-19 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | primary active transmembrane transporter activity |
| GO:0006163 | 2.64523782841e-18 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | purine nucleotide metabolic process |
| GO:1902495 | 3.92109570417e-18 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | transmembrane transporter complex |
| GO:0005743 | 4.11389998219e-18 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | mitochondrial inner membrane |
| GO:0072521 | 4.75184241588e-18 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | purine-containing compound metabolic process |
| KEGG:05022 | 4.76868373288e-18 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Pathways of neurodegeneration - multiple diseases |
| HP:0008316 | 5.34716596492e-18 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Abnormal mitochondria in muscle tissue |
| GO:0033108 | 5.94059797666e-18 | 0.785714285714 | NDUFB3 MT-ND5 NDUFA3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | mitochondrial respiratory chain complex assembly |
| GO:0019866 | 9.24169327446e-18 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | organelle inner membrane |
| GO:0009117 | 9.8941268942e-18 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | nucleotide metabolic process |
| GO:1990351 | 1.11816591263e-17 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | transporter complex |
| GO:0006753 | 1.21171020709e-17 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | nucleoside phosphate metabolic process |
| GO:0090407 | 1.52934350986e-17 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | organophosphate biosynthetic process |
| GO:0098798 | 3.08887958939e-17 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | mitochondrial protein-containing complex |
| HP:0000114 | 3.42983343704e-17 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Proximal tubulopathy |
| GO:0055086 | 6.65293097202e-17 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | nucleobase-containing small molecule metabolic process |
| GO:1901137 | 9.18843873036e-17 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | carbohydrate derivative biosynthetic process |
| HP:0001138 | 1.11338661237e-16 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Optic neuropathy |
| HP:0003737 | 1.33565122995e-16 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Mitochondrial myopathy |
| KEGG:04932 | 2.35082738298e-16 | 0.714285714286 | NDUFB3 NDUFS8 NDUFV3 NDUFB11 NDUFB2 NDUFB9 NDUFA1 NDUFB10 NDUFA7 NDUFA3 | Non-alcoholic fatty liver disease |
| WP:WP4396 | 4.24274479119e-16 | 0.714285714286 | NDUFB3 NDUFS8 NDUFV3 NDUFB11 NDUFB2 NDUFB9 NDUFA1 NDUFB10 NDUFA7 NDUFA3 | Nonalcoholic fatty liver disease |
| GO:0031966 | 4.86539291546e-16 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | mitochondrial membrane |
| HP:0012748 | 8.52985031923e-16 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Focal T2 hyperintense brainstem lesion |
| GO:0005740 | 1.22342124825e-15 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | mitochondrial envelope |
| HP:0007704 | 1.857031302e-15 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Paroxysmal involuntary eye movements |
| HP:0012747 | 3.77147835067e-15 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Abnormal brainstem MRI signal intensity |
| HP:0003800 | 5.77776621029e-15 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Muscle abnormality related to mitochondrial dysfunction |
| GO:0022804 | 6.52803939899e-15 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | active transmembrane transporter activity |
| HP:0000124 | 2.91391609364e-14 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Renal tubular dysfunction |
| GO:0019637 | 3.1145821403e-14 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | organophosphate metabolic process |
| HP:0002490 | 3.5420041187e-14 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Increased CSF lactate |
| HP:0030085 | 3.5420041187e-14 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Abnormal CSF lactate concentration |
| HP:0004366 | 4.5912527735e-14 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Abnormality of glycolysis |
| HP:0003542 | 4.5912527735e-14 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Increased serum pyruvate |
| HP:0003287 | 4.77913975167e-14 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of mitochondrial metabolism |
| GO:1901135 | 8.14623665098e-14 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | carbohydrate derivative metabolic process |
| CORUM:2914 | 9.23910366349e-14 | 0.428571428571 | NDUFB3 MT-ND5 NDUFB11 NDUFB2 NDUFB9 NDUFB10 | Respiratory chain complex I (beta subunit) mitochondrial |
| HP:0025116 | 1.16687610627e-13 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Fetal distress |
| HP:0012103 | 1.77345900853e-13 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the mitochondrion |
| HP:0011013 | 3.95750635834e-13 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Abnormal circulating carbohydrate concentration |
| HP:0025454 | 6.66939205147e-13 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Abnormal CSF metabolite concentration |
| GO:0031975 | 7.20525617138e-13 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | envelope |
| GO:0031967 | 7.20525617138e-13 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | organelle envelope |
| HP:0001639 | 2.02840824102e-12 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Hypertrophic cardiomyopathy |
| HP:0011923 | 4.250829599e-12 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Decreased activity of mitochondrial complex I |
| HP:0000817 | 6.68760865736e-12 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Reduced eye contact |
| HP:0034435 | 6.68760865736e-12 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Abnormal eye contact |
| HP:0002415 | 6.68760865736e-12 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Leukodystrophy |
| HP:0003128 | 9.23851714821e-12 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Lactic acidosis |
| HP:0000758 | 1.1155232096e-11 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Abnormal nonverbal communicative behavior |
| KEGG:01100 | 1.43316697822e-11 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Metabolic pathways |
| GO:0016491 | 2.61317595016e-11 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | oxidoreductase activity |
| GO:0044281 | 4.32319059793e-11 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | small molecule metabolic process |
| GO:0007005 | 6.61207775055e-11 | 0.785714285714 | NDUFB3 MT-ND5 NDUFA3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | mitochondrion organization |
| GO:0005739 | 7.3997804007e-11 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | mitochondrion |
| GO:1901566 | 7.48148144614e-11 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | organonitrogen compound biosynthetic process |
| HP:0008972 | 8.48278682017e-11 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Decreased activity of mitochondrial respiratory chain |
| HP:0011922 | 1.09095295247e-10 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Abnormal activity of mitochondrial respiratory chain |
| HP:0000819 | 1.39013529629e-10 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Diabetes mellitus |
| GO:0098796 | 1.54845156207e-10 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | membrane protein complex |
| HP:0001952 | 1.70820603446e-10 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Glucose intolerance |
| GO:0022857 | 4.82892525903e-10 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | transmembrane transporter activity |
| HP:0001298 | 5.43694721612e-10 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Encephalopathy |
| HP:0002013 | 9.60506543343e-10 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Vomiting |
| HP:0002017 | 1.04358136198e-09 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Nausea and vomiting |
| HP:0001638 | 1.45615455423e-09 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Cardiomyopathy |
| GO:0005215 | 1.8789157722e-09 | 0.857142857143 | NDUFB3 MT-ND5 NDUFV3 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | transporter activity |
| HP:0001637 | 2.30616071001e-09 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal myocardium morphology |
| HP:0011017 | 3.64472935026e-09 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal cellular physiology |
| HP:0000543 | 3.73506065213e-09 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Optic disc pallor |
| HP:0001254 | 3.73506065213e-09 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Lethargy |
| REAC:R-HSA-1430728 | 4.11112298768e-09 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | Metabolism |
| HP:0000745 | 4.62970729459e-09 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Diminished motivation |
| HP:0002421 | 4.71838746316e-09 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Poor head control |
| HP:0002352 | 4.90252223707e-09 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Leukoencephalopathy |
| HP:5200275 | 5.25353926309e-09 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal motivation |
| HP:0001941 | 5.35833585978e-09 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Acidosis |
| HP:0025354 | 5.74423699178e-09 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal cellular phenotype |
| GO:0006796 | 5.80646170979e-09 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | phosphate-containing compound metabolic process |
| GO:0006793 | 6.65288728271e-09 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | phosphorus metabolic process |
| HP:0001943 | 7.38144806318e-09 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Hypoglycemia |
| HP:0011014 | 8.42852549057e-09 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal glucose homeostasis |
| HP:0004360 | 9.16944595611e-09 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Abnormality of acid-base homeostasis |
| HP:0012211 | 9.98435315735e-09 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal renal physiology |
| CORUM:2919 | 1.35498650747e-08 | 0.285714285714 | MT-ND1 NDUFA1 MT-ND2 NDUFA3 | Respiratory chain complex I (gamma subunit) mitochondrial |
| HP:0002363 | 1.68424007276e-08 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Abnormal brainstem morphology |
| HP:0034059 | 1.91693444178e-08 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Abnormal fetal physiology |
| HP:0012795 | 2.56440006506e-08 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal optic disc morphology |
| HP:0000618 | 3.05808053687e-08 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Blindness |
| HP:0011015 | 3.76798938037e-08 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Abnormal blood glucose concentration |
| HP:0034057 | 7.18454562989e-08 | 0.642857142857 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 DNAJC30 MT-ND2 | Fetal anomaly |
| HP:0007663 | 9.13248030893e-08 | 0.642857142857 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 DNAJC30 MT-ND2 | Reduced visual acuity |
| HP:0000587 | 9.49014786657e-08 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal optic nerve morphology |
| GO:1902494 | 1.077480431e-07 | 0.928571428571 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 NDUFB10 | catalytic complex |
| HP:0007768 | 1.17298520533e-07 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Central retinal vessel vascular tortuosity |
| HP:0000631 | 1.17298520533e-07 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Retinal arterial tortuosity |
| HP:0000407 | 1.40294623388e-07 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Sensorineural hearing impairment |
| HP:0002921 | 1.71767291613e-07 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Abnormal cerebrospinal fluid morphology |
| HP:0012447 | 2.27960729255e-07 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Abnormal myelination |
| HP:0002240 | 2.47321054506e-07 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Hepatomegaly |
| HP:0000576 | 2.76186611523e-07 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Centrocecal scotoma |
| HP:0011400 | 3.68124667219e-07 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Abnormal CNS myelination |
| HPA:0241103 | 4.08985285543e-07 | 0.714285714286 | NDUFB3 NDUFS8 NDUFV3 NDUFB11 NDUFB9 MT-ND1 NDUFA1 NDUFB10 NDUFA7 NDUFA3 | heart muscle; cardiomyocytes[High] |
| HP:0011389 | 4.10598849438e-07 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Functional abnormality of the inner ear |
| HP:0001251 | 6.07245403177e-07 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Ataxia |
| HP:0000639 | 6.69822305608e-07 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Nystagmus |
| GO:0031090 | 7.78054132453e-07 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | organelle membrane |
| HP:0012547 | 7.78679443605e-07 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal involuntary eye movements |
| HP:0003271 | 7.83208672112e-07 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Visceromegaly |
| HP:0011277 | 8.12560246485e-07 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the urinary system physiology |
| HP:0001508 | 8.38830178332e-07 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Failure to thrive |
| HP:0001392 | 8.38830178332e-07 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the liver |
| HP:0000505 | 1.11173466998e-06 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Visual impairment |
| HP:0200125 | 1.3242948662e-06 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Mitochondrial respiratory chain defects |
| HP:0001438 | 1.67528423815e-06 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Abnormal abdomen morphology |
| HP:0011443 | 1.94399431957e-06 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of coordination |
| HP:0410042 | 3.70444743198e-06 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Abnormal liver morphology |
| GO:0034654 | 3.85397090668e-06 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | nucleobase-containing compound biosynthetic process |
| HP:0005116 | 4.91098281342e-06 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Arterial tortuosity |
| GO:0018130 | 4.97616369063e-06 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | heterocycle biosynthetic process |
| GO:0019438 | 5.05080491753e-06 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | aromatic compound biosynthetic process |
| HP:0002012 | 5.43059801201e-06 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the abdominal organs |
| HP:0032180 | 5.47797165331e-06 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal circulating metabolite concentration |
| HP:0000504 | 5.67118072495e-06 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of vision |
| HP:0007763 | 5.88995057231e-06 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Retinal telangiectasia |
| HP:0003648 | 5.88995057231e-06 | 0.285714285714 | MT-ND1 MT-ND5 MT-ND2 NDUFB10 | Lacticaciduria |
| HP:0000818 | 7.2031222182e-06 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the endocrine system |
| GO:1901362 | 7.57840746945e-06 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | organic cyclic compound biosynthetic process |
| HP:0001098 | 7.63966030036e-06 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal fundus morphology |
| HP:0001511 | 7.93641160312e-06 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Intrauterine growth retardation |
| HP:0004329 | 7.9657858226e-06 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal posterior eye segment morphology |
| HP:0002093 | 8.79073174586e-06 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Respiratory insufficiency |
| HP:0004948 | 9.71191517502e-06 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Vascular tortuosity |
| HP:0004309 | 9.71191517502e-06 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Ventricular preexcitation |
| HP:0001197 | 1.04328137046e-05 | 0.642857142857 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 DNAJC30 MT-ND2 | Abnormality of prenatal development or birth |
| HP:0000077 | 1.11458800905e-05 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the kidney |
| HP:0010935 | 1.37082403809e-05 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the upper urinary tract |
| GO:0065003 | 1.3927825004e-05 | 0.785714285714 | NDUFB3 MT-ND5 NDUFA3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | protein-containing complex assembly |
| HP:0002151 | 1.57449089058e-05 | 0.428571428571 | MT-ND5 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 | Increased serum lactate |
| HP:0007924 | 1.73741384071e-05 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Slow decrease in visual acuity |
| HP:0001324 | 1.87639199424e-05 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Muscle weakness |
| CORUM:2920 | 2.03024740069e-05 | 0.214285714286 | NDUFV3 NDUFS8 NDUFA7 | Respiratory chain complex I (lambda subunit) mitochondrial |
| HP:0000365 | 2.22229907693e-05 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Hearing impairment |
| HP:0001627 | 2.39401685305e-05 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal heart morphology |
| HP:0000364 | 2.6156385193e-05 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Hearing abnormality |
| HP:0004325 | 2.81411465278e-05 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Decreased body weight |
| HP:0000622 | 3.63485351371e-05 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Blurred vision |
| HP:0031704 | 3.93877907187e-05 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal ear physiology |
| HP:0000508 | 3.96989909943e-05 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Ptosis |
| HP:0000486 | 4.10749644293e-05 | 0.642857142857 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 DNAJC30 MT-ND2 | Strabismus |
| HP:0007364 | 4.34360115924e-05 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Aplasia/Hypoplasia of the cerebrum |
| HP:0000603 | 5.02147437128e-05 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Central scotoma |
| HP:0000549 | 5.48267774936e-05 | 0.642857142857 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 DNAJC30 MT-ND2 | Abnormal conjugate eye movement |
| HP:0001112 | 6.23196568976e-05 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Leber optic atrophy |
| HP:0100611 | 6.23196568976e-05 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Multiple glomerular cysts |
| GO:0044271 | 6.28668170902e-05 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | cellular nitrogen compound biosynthetic process |
| HP:0012337 | 6.53135439653e-05 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal homeostasis |
| HP:0034434 | 8.99636051542e-05 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal communication |
| HP:0000496 | 9.77598405653e-05 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of eye movement |
| HP:0000708 | 0.000116628538554 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Atypical behavior |
| HP:0012841 | 0.000147775563088 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Retinal vascular tortuosity |
| HP:0004323 | 0.000148303127251 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of body weight |
| HP:0001510 | 0.000152873171548 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Growth delay |
| HP:0001252 | 0.000152873171548 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Hypotonia |
| HP:0002174 | 0.000159751213935 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Postural tremor |
| HP:0011805 | 0.000179787286516 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal skeletal muscle morphology |
| HPA:0090182 | 0.000189016897132 | 0.785714285714 | NDUFB3 NDUFS8 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 NDUFB10 NDUFA7 NDUFA3 | cerebellum; cells in granular layer[>=Medium] |
| HP:0000252 | 0.000198777100787 | 0.642857142857 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 DNAJC30 MT-ND2 | Microcephaly |
| HP:0011458 | 0.000203554478295 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abdominal symptom |
| HP:0004885 | 0.000211704739034 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Episodic respiratory distress |
| HP:0000816 | 0.000211704739034 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Abnormality of Krebs cycle metabolism |
| HP:0030680 | 0.000212076211349 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal cardiovascular system morphology |
| HP:0040195 | 0.000215457623818 | 0.642857142857 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 DNAJC30 MT-ND2 | Decreased head circumference |
| HP:0002977 | 0.000217086997102 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Aplasia/Hypoplasia involving the central nervous system |
| CORUM:2886 | 0.000266552996475 | 0.142857142857 | MT-ND1 MT-ND2 | Respiratory chain complex I (incomplete intermediate ND1, ND2, ND3, CIA30 assembly), mitochondrial |
| HP:0002795 | 0.000273106435611 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Abnormal respiratory system physiology |
| HP:0003348 | 0.000283452054181 | 0.285714285714 | MT-ND1 MT-ND5 MT-ND2 NDUFB10 | Hyperalaninemia |
| HP:0000630 | 0.000283452054181 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Abnormal retinal artery morphology |
| HP:0011442 | 0.000299186087601 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal central motor function |
| HP:0010915 | 0.00030283424632 | 0.285714285714 | MT-ND1 MT-ND5 MT-ND2 NDUFB10 | Abnormal circulating pyruvate family amino acid concentration |
| HP:0010916 | 0.00030283424632 | 0.285714285714 | MT-ND1 MT-ND5 MT-ND2 NDUFB10 | Abnormal circulating alanine concentration |
| HP:0000079 | 0.000311180625462 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the urinary system |
| HP:0003572 | 0.000336422712348 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Low plasma citrulline |
| HP:0003481 | 0.000336422712348 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Segmental peripheral demyelination/remyelination |
| HP:0001427 | 0.000336422712348 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Mitochondrial inheritance |
| HP:0004308 | 0.000392808325652 | 0.357142857143 | DNAJC30 NDUFB11 MT-ND1 MT-ND5 MT-ND2 | Ventricular arrhythmia |
| HP:0000575 | 0.000414954573136 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Scotoma |
| HP:0002086 | 0.000484527569007 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the respiratory system |
| HP:0002060 | 0.000502922954725 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal cerebral morphology |
| GO:0043933 | 0.000510329310615 | 0.785714285714 | NDUFB3 MT-ND5 NDUFA3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | protein-containing complex organization |
| HP:3000036 | 0.000524867113486 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Abnormal head blood vessel morphology |
| HP:0033108 | 0.000524867113486 | 0.285714285714 | MT-ND1 MT-ND5 MT-ND2 NDUFB10 | Abnormal circulating proteinogenic amino acid derivative concentration |
| HP:0100547 | 0.000582866599881 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal forebrain morphology |
| CORUM:2939 | 0.000665653089703 | 0.142857142857 | MT-ND1 NDUFA1 | Ecsit complex (ECSIT, MT-CO2, NDUFA1, MT-ND1, TRAF6, NDUFAF1) |
| HP:0003808 | 0.000773432233443 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal muscle tone |
| GO:0006139 | 0.0008102316605 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | nucleobase-containing compound metabolic process |
| HP:0011965 | 0.000840527836729 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Abnormal circulating citrulline concentration |
| HP:0000572 | 0.00090147538453 | 0.357142857143 | DNAJC30 NDUFB11 MT-ND1 MT-ND5 MT-ND2 | Visual loss |
| HP:0000240 | 0.000931551891877 | 0.642857142857 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 DNAJC30 MT-ND2 | Abnormality of skull size |
| HP:0000091 | 0.000986144585081 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Abnormal renal tubule morphology |
| HP:0002381 | 0.00103488334346 | 0.285714285714 | NDUFB11 NDUFA1 MT-ND5 MT-ND1 | Aphasia |
| HP:0011968 | 0.00109441043956 | 0.571428571429 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 MT-ND2 | Feeding difficulties |
| HP:0025032 | 0.00114929661194 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of digestive system physiology |
| GO:0046483 | 0.00121860640274 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | heterocycle metabolic process |
| GO:0006725 | 0.00127279775142 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | cellular aromatic compound metabolic process |
| GO:1901564 | 0.00133810344335 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | organonitrogen compound metabolic process |
| WP:000000 | 0.00138191413625 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | WIKIPATHWAYS |
| WP:000000 | 0.00138191413625 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | WIKIPATHWAYS |
| HPA:0471452 | 0.00145288512066 | 0.285714285714 | NDUFV3 NDUFA7 NDUFA3 NDUFB11 | skin 2; hair follicles[>=Medium] |
| HP:0000598 | 0.00147318089702 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the ear |
| HP:0000529 | 0.00200244671597 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Progressive visual loss |
| GO:1901360 | 0.00210982498355 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | organic cyclic compound metabolic process |
| HP:0033109 | 0.00214810556123 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Abnormal circulating non-proteinogenic amino acid concentration |
| HP:0007183 | 0.00214810556123 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Focal T2 hyperintense basal ganglia lesion |
| HP:0012372 | 0.00216903598796 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal eye morphology |
| HP:0012373 | 0.00230974086129 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal eye physiology |
| HP:0001939 | 0.00280606863804 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of metabolism/homeostasis |
| HP:0012072 | 0.00294313380384 | 0.285714285714 | MT-ND1 MT-ND5 MT-ND2 NDUFB10 | Aciduria |
| HP:0011804 | 0.00310133481673 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal muscle physiology |
| HP:0032943 | 0.00316488990406 | 0.285714285714 | MT-ND1 MT-ND5 MT-ND2 NDUFB10 | Abnormal urine pH |
| HP:0002883 | 0.00329365362554 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Hyperventilation |
| HPA:0471451 | 0.00339404742152 | 0.285714285714 | NDUFV3 NDUFA7 NDUFA3 NDUFB11 | skin 2; hair follicles[>=Low] |
| HP:0000119 | 0.00366525106 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the genitourinary system |
| HPA:0271112 | 0.00368996146892 | 0.285714285714 | NDUFV3 NDUFA1 NDUFA3 NDUFB11 | kidney; bowman's capsule[>=Medium] |
| GO:0034641 | 0.00390177162411 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | cellular nitrogen compound metabolic process |
| HP:0012443 | 0.00400499352643 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal brain morphology |
| HPA:0471392 | 0.00420789584797 | 0.428571428571 | NDUFV3 NDUFA3 NDUFB11 NDUFA1 NDUFA7 NDUFB10 | skin 2; cells in basal layer[>=Medium] |
| HP:0001263 | 0.00441098479157 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Global developmental delay |
| HP:0001507 | 0.004482580041 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Growth abnormality |
| HP:0003198 | 0.00452417993419 | 0.357142857143 | DNAJC30 NDUFB3 MT-ND1 MT-ND5 MT-ND2 | Myopathy |
| HP:0002123 | 0.00461359753373 | 0.285714285714 | MT-ND1 NDUFA1 MT-ND5 MT-ND2 | Generalized myoclonic seizure |
| HP:0001626 | 0.00471053627808 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the cardiovascular system |
| HP:0012751 | 0.00521698331334 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Abnormal basal ganglia MRI signal intensity |
| HPA:0540053 | 0.00593230485198 | 0.642857142857 | NDUFB3 NDUFA3 NDUFV3 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA7 NDUFA1 | stomach 1; glandular cells[High] |
| HP:0000556 | 0.00594114009694 | 0.357142857143 | NDUFB11 MT-ND1 NDUFA1 MT-ND5 MT-ND2 | Retinal dystrophy |
| HP:0002483 | 0.00615696919658 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Bulbar signs |
| HP:0002045 | 0.00615696919658 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Hypothermia |
| HPA:0090162 | 0.00664518196418 | 0.785714285714 | NDUFB3 NDUFS8 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 NDUFB10 NDUFA7 NDUFA3 | cerebellum; Purkinje cells[>=Medium] |
| HP:0000408 | 0.00666628179151 | 0.214285714286 | MT-ND1 MT-ND5 NDUFA1 | Progressive sensorineural hearing impairment |
| HP:0011096 | 0.00776696493391 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Peripheral demyelination |
| HPA:0030053 | 0.00797576786774 | 0.571428571429 | NDUFB3 NDUFA3 NDUFV3 NDUFB11 NDUFB9 NDUFB10 NDUFA7 NDUFA1 | appendix; glandular cells[High] |
| HP:0002011 | 0.00798354766323 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Morphological central nervous system abnormality |
| HP:0001009 | 0.00891490205863 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Telangiectasia |
| HPA:0471411 | 0.00932028490102 | 0.428571428571 | NDUFV3 NDUFA3 NDUFB11 NDUFA1 NDUFA7 NDUFB10 | skin 2; cells in spinous layer[>=Low] |
| HP:0003011 | 0.00956069821263 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the musculature |
| HP:0001644 | 0.00967373720509 | 0.285714285714 | NDUFB11 MT-ND1 MT-ND5 MT-ND2 | Dilated cardiomyopathy |
| HP:0025031 | 0.00974366053524 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the digestive system |
| HP:0003112 | 0.0099369818377 | 0.285714285714 | MT-ND1 MT-ND5 MT-ND2 NDUFB10 | Abnormal circulating amino acid concentration |
| HPA:0461391 | 0.0103158671376 | 0.428571428571 | NDUFV3 NDUFA3 NDUFB11 NDUFA1 NDUFA7 NDUFB10 | skin 1; cells in basal layer[>=Low] |
| HP:0012639 | 0.0105859297624 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormal nervous system morphology |
| GO:0022607 | 0.0105880493962 | 0.785714285714 | NDUFB3 MT-ND5 NDUFA3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | cellular component assembly |
| HPA:0271111 | 0.0106158379531 | 0.285714285714 | NDUFV3 NDUFA1 NDUFA3 NDUFB11 | kidney; bowman's capsule[>=Low] |
| HP:0012759 | 0.0109077665448 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Neurodevelopmental abnormality |
| HPA:0241102 | 0.0109500059759 | 0.785714285714 | NDUFB3 NDUFS8 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 NDUFB10 NDUFA7 NDUFA3 | heart muscle; cardiomyocytes[>=Medium] |
| HP:0001730 | 0.0110290654103 | 0.214285714286 | MT-ND1 MT-ND5 NDUFA1 | Progressive hearing impairment |
| HPA:0271123 | 0.0114683375839 | 0.285714285714 | NDUFV3 NDUFA1 NDUFA3 NDUFB11 | kidney; collecting ducts[High] |
| HP:0002572 | 0.0117743906789 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Episodic vomiting |
| HPA:0470182 | 0.0129982604305 | 0.357142857143 | NDUFV3 NDUFA7 NDUFB10 NDUFA3 NDUFB11 | skin 2; cells in granular layer[>=Medium] |
| HP:0000580 | 0.0138626661294 | 0.285714285714 | NDUFB11 MT-ND1 MT-ND5 MT-ND2 | Pigmentary retinopathy |
| HP:0000478 | 0.0146860175038 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the eye |
| HP:0032677 | 0.0156413586059 | 0.285714285714 | MT-ND1 NDUFA1 MT-ND5 MT-ND2 | Generalized-onset motor seizure |
| HP:0003200 | 0.0160024485897 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Ragged-red muscle fibers |
| HPA:0090181 | 0.0164431552768 | 0.785714285714 | NDUFB3 NDUFS8 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 NDUFB10 NDUFA7 NDUFA3 | cerebellum; cells in granular layer[>=Low] |
| HPA:0471391 | 0.0164618661599 | 0.428571428571 | NDUFV3 NDUFA3 NDUFB11 NDUFA1 NDUFA7 NDUFB10 | skin 2; cells in basal layer[>=Low] |
| HP:0007108 | 0.0169530104322 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Demyelinating peripheral neuropathy |
| HPA:0471482 | 0.0172494549819 | 0.214285714286 | NDUFV3 NDUFA7 NDUFB11 | skin 2; sebaceous glands[>=Medium] |
| HP:0002345 | 0.0175831264937 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Action tremor |
| HPA:0271133 | 0.0181596676245 | 0.285714285714 | NDUFV3 NDUFA1 NDUFA3 NDUFB11 | kidney; distal tubules[High] |
| HP:0100660 | 0.0188303048542 | 0.285714285714 | MT-ND1 MT-ND5 NDUFS8 MT-ND2 | Dyskinesia |
| HP:0011446 | 0.0195736247762 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of mental function |
| HP:0001271 | 0.0200265187635 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Polyneuropathy |
| HP:0000929 | 0.0214022425946 | 0.642857142857 | NDUFB3 NDUFS8 NDUFB11 NDUFB9 MT-ND1 NDUFB10 NDUFA1 DNAJC30 MT-ND2 | Abnormal skull morphology |
| HP:0000924 | 0.0237407842594 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the skeletal system |
| HP:0002098 | 0.0244804696999 | 0.285714285714 | NDUFB11 MT-ND1 MT-ND5 MT-ND2 | Respiratory distress |
| HP:0000510 | 0.0255312236602 | 0.285714285714 | MT-ND1 NDUFA1 MT-ND5 MT-ND2 | Rod-cone dystrophy |
| HP:0000234 | 0.0266352667794 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of the head |
| HPA:0470672 | 0.0272902562049 | 0.357142857143 | NDUFV3 NDUFA7 NDUFB10 NDUFA3 NDUFB11 | skin 2; melanocytes[>=Medium] |
| HP:0012758 | 0.0273356261934 | 0.642857142857 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | Neurodevelopmental delay |
| GO:0044085 | 0.027791854666 | 0.785714285714 | NDUFB3 MT-ND5 NDUFA3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 NDUFB10 | cellular component biogenesis |
| HP:0000152 | 0.0289572522308 | 0.714285714286 | NDUFB3 MT-ND5 NDUFB11 NDUFB9 MT-ND1 MT-ND2 NDUFS8 NDUFA1 DNAJC30 NDUFB10 | Abnormality of head or neck |
| HPA:0471481 | 0.0298911814053 | 0.214285714286 | NDUFV3 NDUFA7 NDUFB11 | skin 2; sebaceous glands[>=Low] |
| HPA:0471462 | 0.0301176643774 | 0.357142857143 | NDUFV3 NDUFA7 NDUFB10 NDUFA3 NDUFB11 | skin 2; langerhans cells[>=Medium] |
| HP:0011675 | 0.03365336927 | 0.357142857143 | DNAJC30 NDUFB11 MT-ND1 MT-ND5 MT-ND2 | Arrhythmia |
| HPA:0471412 | 0.0341495417769 | 0.357142857143 | NDUFV3 NDUFA7 NDUFB10 NDUFA3 NDUFB11 | skin 2; cells in spinous layer[>=Medium] |
| HPA:0100211 | 0.0353388859281 | 0.785714285714 | NDUFB3 NDUFS8 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 NDUFB10 NDUFA7 NDUFA3 | cerebral cortex; neuropil[>=Low] |
| HP:0002104 | 0.0365447853154 | 0.285714285714 | MT-ND1 MT-ND5 NDUFS8 MT-ND2 | Apnea |
| HP:0031434 | 0.0392355511504 | 0.214285714286 | MT-ND1 MT-ND5 MT-ND2 | Abnormal prosody |
| HP:0002072 | 0.0394021027144 | 0.285714285714 | MT-ND1 NDUFA1 MT-ND5 MT-ND2 | Chorea |
| HP:0007327 | 0.0406149250495 | 0.142857142857 | MT-ND1 MT-ND5 | Mixed demyelinating and axonal polyneuropathy |
| HPA:0470181 | 0.041681565569 | 0.357142857143 | NDUFV3 NDUFA7 NDUFB10 NDUFA3 NDUFB11 | skin 2; cells in granular layer[>=Low] |
| GO:0044249 | 0.0429321940113 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | cellular biosynthetic process |
| HP:0032794 | 0.0432006386307 | 0.285714285714 | MT-ND1 NDUFA1 MT-ND5 MT-ND2 | Myoclonic seizure |
| HPA:0090183 | 0.0437495437628 | 0.357142857143 | NDUFV3 NDUFA7 NDUFA1 NDUFA3 NDUFB11 | cerebellum; cells in granular layer[High] |
| HP:0008046 | 0.044792888014 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Abnormal retinal vascular morphology |
| HP:0012575 | 0.045604973854 | 0.285714285714 | DNAJC30 MT-ND1 MT-ND5 MT-ND2 | Abnormal nephron morphology |
| HP:0011004 | 0.0477753149351 | 0.357142857143 | DNAJC30 NDUFB11 MT-ND1 MT-ND5 MT-ND2 | Abnormal systemic arterial morphology |
| GO:1901576 | 0.0481113191273 | 1.0 | NDUFB3 MT-ND5 NDUFV3 NDUFB11 NDUFB2 NDUFB9 MT-ND1 NDUFA1 MT-ND2 NDUFS8 NDUFA3 NDUFA7 DNAJC30 NDUFB10 | organic substance biosynthetic process |
| HPA:0470671 | 0.0487719162838 | 0.357142857143 | NDUFV3 NDUFA7 NDUFB10 NDUFA3 NDUFB11 | skin 2; melanocytes[>=Low] |
| HP:0001635 | 0.0489618075031 | 0.285714285714 | NDUFB11 MT-ND1 MT-ND5 DNAJC30 | Congestive heart failure |
| HP:0005157 | 0.0496132916372 | 0.142857142857 | MT-ND1 MT-ND5 | Concentric hypertrophic cardiomyopathy |
| HPA:0550053 | 0.0496231540166 | 0.571428571429 | NDUFB3 NDUFA3 NDUFV3 NDUFB11 NDUFB9 MT-ND1 NDUFA1 NDUFA7 | stomach 2; glandular cells[High] |
Edges
| Protein 1 | Protein 2 | Score | ProteomeHD |
|---|---|---|---|
| NDUFS8 | NDUFA7 | 1.0 | 0.778 |
| NDUFB11 | NDUFA1 | 1.0 | 0.66 |
| NDUFB11 | MT-ND5 | 1.0 | 0.356 |
| NDUFB11 | NDUFB10 | 1.0 | 0.902 |
| NDUFV3 | NDUFA7 | 0.999 | 0.61 |
| NDUFV3 | NDUFB11 | 0.999 | 0.228 |
| NDUFB11 | NDUFA3 | 0.999 | 0.758 |
| NDUFV3 | NDUFS8 | 0.999 | 0.518 |
| NDUFB11 | NDUFB9 | 0.999 | 0.756 |
| NDUFB11 | NDUFA7 | 0.999 | 0.338 |
| NDUFB11 | NDUFB3 | 0.999 | 0.922 |
| NDUFB11 | DNAJC30 | 0.999 | 0.182 |
| NDUFB11 | NDUFS8 | 0.999 | 0.89 |
| NDUFV3 | DNAJC30 | 0.999 | 0.104 |
| NDUFV3 | NDUFB9 | 0.999 | 0.434 |
| NDUFV3 | NDUFB10 | 0.999 | 0.62 |
| NDUFV3 | NDUFA3 | 0.999 | 0.266 |
| NDUFA7 | NDUFA1 | 0.999 | 0.878 |
| NDUFV3 | NDUFA1 | 0.999 | 0.412 |
| NDUFB3 | NDUFA7 | 0.999 | 0.966 |
| NDUFA3 | NDUFA7 | 0.999 | 0.926 |
| NDUFV3 | MT-ND1 | 0.998 | 0.43 |
| NDUFV3 | NDUFB3 | 0.998 | 0.434 |
| NDUFB10 | NDUFA7 | 0.998 | 0.57 |
| NDUFV3 | MT-ND2 | 0.998 | 0.27 |
| DNAJC30 | NDUFA7 | 0.998 | 0.222 |
| NDUFB3 | NDUFA1 | 0.998 | 0.902 |
| MT-ND5 | NDUFA1 | 0.998 | 0.71 |
| NDUFB3 | MT-ND2 | 0.998 | 0.942 |
| NDUFB2 | NDUFV3 | 0.998 | 0.208 |
| NDUFB10 | NDUFA1 | 0.997 | 0.898 |
| NDUFV3 | MT-ND5 | 0.997 | 0.514 |
| NDUFB9 | NDUFA7 | 0.997 | 0.996 |
| NDUFB9 | NDUFA1 | 0.997 | 0.786 |
| NDUFA7 | MT-ND2 | 0.997 | 0.892 |
| NDUFA7 | MT-ND1 | 0.997 | 0.73 |
| NDUFB11 | MT-ND1 | 0.996 | 0.136 |
| MT-ND1 | NDUFA1 | 0.996 | 0.52 |
| NDUFA3 | NDUFA1 | 0.996 | 0.704 |
| NDUFB3 | NDUFB9 | 0.996 | 0.992 |
| NDUFB3 | NDUFB10 | 0.996 | 0.982 |
| NDUFB11 | MT-ND2 | 0.996 | 0.652 |
| NDUFS8 | NDUFA1 | 0.995 | 0.698 |
| NDUFA7 | MT-ND5 | 0.995 | 0.828 |
| NDUFB2 | NDUFA1 | 0.994 | 0.69 |
| NDUFB3 | NDUFS8 | 0.993 | 0.938 |
| NDUFB3 | MT-ND5 | 0.992 | 0.858 |
| DNAJC30 | NDUFB3 | 0.992 | 0.29 |
| NDUFB3 | NDUFA3 | 0.991 | 0.958 |
| NDUFB2 | DNAJC30 | 0.99 | 0.178 |
| NDUFB2 | NDUFB3 | 0.987 | 0.906 |
| NDUFB10 | NDUFS8 | 0.987 | 0.952 |
| NDUFB3 | MT-ND1 | 0.985 | 0.528 |
| NDUFB9 | MT-ND1 | 0.985 | 0.874 |
| DNAJC30 | NDUFA1 | 0.985 | 0.09 |
| NDUFB9 | NDUFS8 | 0.983 | 0.98 |
| NDUFS8 | MT-ND5 | 0.981 | 0.518 |
| NDUFS8 | MT-ND1 | 0.979 | 0.41 |
| NDUFS8 | NDUFA3 | 0.978 | 0.934 |
| NDUFB2 | NDUFA7 | 0.978 | 0.69 |
| NDUFB10 | MT-ND1 | 0.978 | 0.338 |
| DNAJC30 | MT-ND5 | 0.977 | 0.11 |
| NDUFB10 | MT-ND5 | 0.976 | 0.54 |
| MT-ND5 | MT-ND2 | 0.975 | 0.692 |
| NDUFB9 | MT-ND5 | 0.974 | 0.886 |
| NDUFB10 | NDUFA3 | 0.974 | 0.902 |
| DNAJC30 | NDUFA3 | 0.973 | 0.156 |
| DNAJC30 | NDUFS8 | 0.97 | 0.266 |
| DNAJC30 | MT-ND1 | 0.968 | 0.108 |
| NDUFB10 | MT-ND2 | 0.965 | 0.848 |
| DNAJC30 | NDUFB9 | 0.964 | 0.136 |
| NDUFB10 | NDUFB9 | 0.962 | 0.932 |
| NDUFB9 | MT-ND2 | 0.961 | 0.94 |
| NDUFA3 | MT-ND2 | 0.956 | 0.928 |
| MT-ND1 | MT-ND2 | 0.954 | 0.838 |
| NDUFS8 | MT-ND2 | 0.953 | 0.902 |
| DNAJC30 | NDUFB10 | 0.941 | 0.31 |
| MT-ND1 | MT-ND5 | 0.941 | 0.528 |
| NDUFA3 | MT-ND1 | 0.938 | 0.35 |
| NDUFB9 | NDUFA3 | 0.925 | 0.97 |
| NDUFA3 | MT-ND5 | 0.925 | 0.29 |
| MT-ND2 | NDUFA1 | 0.814 | 0.754 |
| DNAJC30 | MT-ND2 | 0.811 | 0.168 |
| NDUFB2 | NDUFB9 | 0.786 | 0.944 |
| NDUFB2 | MT-ND2 | 0.772 | 0.846 |
| NDUFB2 | NDUFB11 | 0.761 | 0.392 |
| NDUFB2 | NDUFB10 | 0.761 | 0.738 |
| NDUFB2 | NDUFS8 | 0.761 | 0.684 |
| NDUFB2 | NDUFA3 | 0.709 | 0.678 |
| NDUFB2 | MT-ND5 | 0.709 | 0.324 |
| NDUFB2 | MT-ND1 | 0.709 | 0.404 |
Related Complexes